Curcumin Completed Phase 4 Trials for Chronic Schizophrenia Treatment

IndicationsStatusPurposePhase
CompletedTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT02298985Curcumin Addition to Antipsychotic Treatment in Chronic Schizophrenia Patients